Filing Details
- Accession Number:
- 0001754632-22-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-08 17:24:15
- Reporting Period:
- 2022-06-06
- Accepted Time:
- 2022-06-08 17:24:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874866 | Corvel Corp | CRVL | Insurance Agents, Brokers & Service (6411) | 330282651 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1754632 | Jennifer Yoss | 5128 Apache Plume Road, Suite 400 Fort Worth TX 75109 | Vice President Of Accounting | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-06 | 1,600 | $59.32 | 1,889 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-06-06 | 1,600 | $141.14 | 289 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-06-06 | 94 | $49.40 | 383 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-06-06 | 94 | $141.14 | 289 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-06-06 | 94 | $0.00 | 94 | $49.40 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-06-06 | 1,600 | $0.00 | 1,600 | $59.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-05-03 | No | 4 | M | Direct | |
0 | 2023-11-01 | No | 4 | M | Direct |
Footnotes
- Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.
- Option will vest based on achievement of certain performance criteria relating to earnings growth.